Centers for Disease Control and Prevention
922
47
69
730
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.9%
45 terminated/withdrawn out of 922 trials
94.2%
+7.7% vs industry average
17%
160 trials in Phase 3/4
18%
128 of 730 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (922)
A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans
Role: lead
Study of Intradermal Administration of PCEC Rabies Vaccine
Role: lead
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Role: lead
Further MT for Antibiotic-Resistant Bacterial Colonization
Role: collaborator
Tuberculosis Clinical Trials Consortium Study 35
Role: lead
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
Role: lead
Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial
Role: lead
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Role: collaborator
Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens
Role: collaborator
Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home
Role: collaborator
Genomics and COVID-19 Vaccine Adverse Events
Role: collaborator
Evaluation of Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Violence
Role: collaborator
Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation
Role: collaborator
Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand
Role: collaborator
The National Amyotrophic Lateral Sclerosis Registry
Role: lead
Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic
Role: collaborator
Project IntERact V2
Role: collaborator
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
Role: lead
Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)
Role: collaborator
Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care Point of Entry
Role: collaborator